Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2017 1
2018 5
2019 15
2020 11
2021 4
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.
Ansell SM, Radford J, Connors JM, Długosz-Danecka M, Kim WS, Gallamini A, Ramchandren R, Friedberg JW, Advani R, Hutchings M, Evens AM, Smolewski P, Savage KJ, Bartlett NL, Eom HS, Abramson JS, Dong C, Campana F, Fenton K, Puhlmann M, Straus DJ; ECHELON-1 Study Group. Ansell SM, et al. Among authors: dlugosz danecka m. N Engl J Med. 2022 Jul 28;387(4):310-320. doi: 10.1056/NEJMoa2206125. Epub 2022 Jul 13. N Engl J Med. 2022. PMID: 35830649 Clinical Trial.
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.
Straus DJ, Długosz-Danecka M, Connors JM, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Ramchandren R, Zinzani PL, Hutchings M, Munoz J, Lee HJ, Kim WS, Advani R, Ansell SM, Younes A, Gallamini A, Liu R, Little M, Fenton K, Fanale M, Radford J. Straus DJ, et al. Among authors: dlugosz danecka m. Lancet Haematol. 2021 Jun;8(6):e410-e421. doi: 10.1016/S2352-3026(21)00102-2. Lancet Haematol. 2021. PMID: 34048680 Clinical Trial.
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors.
Le Gouill S, Długosz-Danecka M, Rule S, Zinzani PL, Goy A, Smith SD, Doorduijn JK, Panizo C, Shah BD, Davies AJ, Eek R, Jacobsen E, Kater AP, Robak T, Jain P, Calvo R, Tao L, Wang M. Le Gouill S, et al. Among authors: dlugosz danecka m. Haematologica. 2024 Jan 1;109(1):343-350. doi: 10.3324/haematol.2022.282469. Haematologica. 2024. PMID: 37470152 Free PMC article. No abstract available.
Rituximab biosimilars for lymphoma in Europe.
Jurczak W, Długosz Danecka M, Buske C. Jurczak W, et al. Among authors: dlugosz danecka m. Expert Opin Biol Ther. 2019 Oct;19(10):1045-1056. doi: 10.1080/14712598.2019.1665017. Expert Opin Biol Ther. 2019. PMID: 31512535 Review.
Avatrombopag for the treatment of immune thrombocytopenia.
Długosz-Danecka M, Zdziarska J, Jurczak W. Długosz-Danecka M, et al. Expert Rev Clin Immunol. 2019 Apr;15(4):327-339. doi: 10.1080/1744666X.2019.1587294. Epub 2019 Mar 8. Expert Rev Clin Immunol. 2019. PMID: 30799645 Review.
Acalabrutinib for adults with mantle cell lymphoma.
Jurczak W, Długosz-Danecka M, Wang M. Jurczak W, et al. Among authors: dlugosz danecka m. Expert Rev Clin Pharmacol. 2019 Mar;12(3):179-187. doi: 10.1080/17512433.2019.1568868. Epub 2019 Jan 26. Expert Rev Clin Pharmacol. 2019. PMID: 30638402 Review.
Rituximab biosimilars in clinical practice.
Jurczak W, Długosz-Danecka M. Jurczak W, et al. Among authors: dlugosz danecka m. Leuk Lymphoma. 2020 Jul;61(7):1523-1524. doi: 10.1080/10428194.2020.1788016. Epub 2020 Jul 6. Leuk Lymphoma. 2020. PMID: 32628057 No abstract available.
Cardio-oncology for better lymphoma therapy outcomes.
Jurczak W, Długosz-Danecka M, Szmit S. Jurczak W, et al. Among authors: dlugosz danecka m. Lancet Haematol. 2020 Apr;7(4):e273-e275. doi: 10.1016/S2352-3026(20)30066-1. Epub 2020 Mar 2. Lancet Haematol. 2020. PMID: 32135129 No abstract available.
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.
Evens AM, Connors JM, Younes A, Ansell SM, Kim WS, Radford J, Feldman T, Tuscano J, Savage KJ, Oki Y, Grigg A, Pocock C, Dlugosz-Danecka M, Fenton K, Forero-Torres A, Liu R, Jolin H, Gautam A, Gallamini A. Evens AM, et al. Among authors: dlugosz danecka m. Haematologica. 2022 May 1;107(5):1086-1094. doi: 10.3324/haematol.2021.278438. Haematologica. 2022. PMID: 34162178 Free PMC article.
47 results